ePosters
Neuromodulation therapies’ eligibility and success criteria currently relies mainly on unidimensional pain scores (ie NRS/VAS), inadequately reflecting the biopsychosocial complexity of pain. Composite outcomes are a combination of at least two parameters to describe the multidimensional aspect of pain and capture a more comprehensive experience of patients’ response to neuromodulation treatment. This review synthesized existing literature on the clinical utility of composite outcomes in evaluating efficacy of neuromodulation therapies for refractory pain.
Gretchen Mae Gabriel, MD, DPBA
Clinical Fellow
1Department Of Anesthesiology and Pain Medicine, University of Toronto-Toronto Western Hospital, Toronto, Ontario Canada
Toronto, Ontario, Canada
Olivia S. Chung, BHSc
Medical student
University of Toronto
North York, Ontario, Canada
Abeer Alomari, MD
Assistant Professor
University of Toronto, United States
Lisa Goudman, PhD
Assistant Professor
Uz Brussel Department of Neurosurgery/Radiology, Belgium, 2STIMULUS Research Group, Vrije Universiteit Brussel, Belgium, United States
Maarten Moens, MD, PhD
Professor
Uz Brussel Department of Neurosurgery/Radiology, Belgium, 2STIMULUS Research Group, Vrije Universiteit Brussel, Belgium, United States
Philippe Rigoard, MD, PhD
Professor Neurosurgery
4Spine & Neuromodulation Unit, Department Neurosurgery, Poitiers University Hospital, France; N3Lab; 5Neuromodulation and &Neural Networks PRISMATICS Lab, Poitiers University Hospital, France, United States
Anuj Bhatia, MBBS MD PhD FRCPC
Professor, University of Toronto
University Health Network- Toronto Western Hospital
Toronto, Ontario, Canada
Marina Englesakis, BA (Hons), MLIS
Information Specialist
General Surgery, Anesthesia, & Perioperative Care Education Investigator 1, The Institute of Education Research Library & Information Services, University Health Network, United States